期刊文献+

机器人辅助腹腔镜根治性前列腺切除术130例 被引量:13

Robot-assisted laparoscopic radical prostatectomy of 130 cases
原文传递
导出
摘要 目的 评估da Vinci S机器人辅助腹腔镜根治性前列腺切除术(RARP)的疗效和安全性.方法 回顾分析2009年7月至2013年9月,复旦大学附属中山医院应用da Vinci S手术系统(da Vinci Intuitive Surgical Inc.,Sunnyvale,CA,USA.)完成RARP术130例的情况.年龄48~76岁,平均(67±6)岁;PSA水平为2.16~ 78.20 ng/ml,平均(26.05±8.41)ng/ml;Gleason评分6~10;肿瘤临床分期均为局限性前列腺癌.结果 130例均经腹腔途径,采用机器人3臂或4臂,5~6枚troc ar完成RARP,无机器人机械故障或其他原因导致的术式改变.术前机器人准备时间20 ~ 90 min,平均(48.5±15.4) min;手术时间90 ~ 300 min,平均(143.6±22.9) min;术中出血量50 ~ 600 ml,平均(158.2±59.6) ml,2例(1.5%)术后输血400ml.术后2~3d下床活动,平均(2.2±0.6)d;术后住院5~21d,平均(6.6±1.9)d;4~21d拔除导尿管,平均(6.1±2.0)d.术后主要并发症包括:漏尿6例(4.6%),漏尿于术后3~15d停止.术后淋巴瘘8例(6.2%),术后2~3周停止,未发现淋巴囊肿.术后下肢静脉栓塞、肺栓塞和附睾炎各1例,治疗后好转.术后病理切缘阳性12例(9.2%),精囊见癌侵犯10例(7.7%),闭孔淋巴结转移4例(3.1%).术后1~12个月复查PSA均< 0.2 ng/ml,术后6个月和1年完全控尿率达86%和95%.结论RARP安全、可靠,具有出血更少、恢复更快等优势,是根治性前列腺切除术的首选方式. Objective To assess the efficiency and safety of robot-assisted laparoscopic radical prostectomy (RARP). Methods A retrospective chart review was perfomed, 130 patients radical prostatectomy (RARP) with da Vinci S surgical system (da Vinci Intuitive Surgical Inc., Sunnyvale, CA, USA )from July 2009 to September 2013 localized prostate cancer underwent robot-assisted. The clinical data of patients underwent RARP were analyzed. The age range was 48 - 76years, mean (67 - 6)years. The PSA level range was 2.16 N 78.20ng/mL, mean (26.05 ± 8.41)ng/mL. Gleason score was 6 - 10. Tumor clinical stage of all patients are localized prostate cancer. Results All 130 patients received successful robot-assisted operation and encountered no technique events. A five or six ports transperitonealapproach using a 3 or 4-arm da Vinci S surgical system was used to perform RARP. The preoperative set up time of the da Vinci S surgical system was 20 - 90rain, mean ( 48.5 ± 15.4 )rain. The operating time range was 90 - 300rain, mean (143.6 ± 22.9)rain. The estimated blood loss was 50-600ml, mean ( 158.2 ± 59.6 )ml, and 2 (1.5%) patients need transfusion. The patients were ambulant between 2nd and 3rd postoperative day, mean (2.2 + 0.6)d and discharged on postoperative day 5 to 21, mean ( 6.6 ± 1.9 )d. Foley catheter was removed on postoperative day 4 to 21, mean ( 6.1 ± 2.0 )d. The main postoperative complications including: the urinary leak in six patients (4.6%), prolonged lymphorrhea in eight patients (6.2%), but not presented any form of lymphocele. Deep vein thrombosis, pulmonary embolism and epididymitis presented in one patient respectively. Histopathology confirmed in positive surgical margin 12 (9.2%) cases, seminal vesicle invasion in l0 (7.7%)cases and lymph node invasion in 4 (3.1%) cases. The PSA was less than 0.2 ng/ml during follow-up of one to twelve months postoperatively. The pad-free continence rate was 86% and 95% in postoperative month 6 and one year respectively. Conclusions Robot-assisted lapmoscopic radical prostatectomy has the advantage of mini-invasiveness, less blood loss, rapid postoperative recovery. It is safe,reliable and feasible. RARP should be taken as the first choice for radical prostatectomy.
出处 《中华腔镜外科杂志(电子版)》 2013年第5期35-39,共5页 Chinese Journal of Laparoscopic Surgery(Electronic Edition)
关键词 机器人 前列腺癌 机器人辅助腹腔镜根治性前列腺切除术 Robotics Prostate cancer Robot-assisted laparoscopic radical prostatectomy
  • 相关文献

参考文献25

  • 1Menon M, Shrivastava A, Tewari A,et al. Laparoscopic androbot assisted radical prostatectomy: establishment of a structuredprogram and preliminary analysis of outcomes. J Urol, 2002,168(3):945-949.
  • 2Tewari A, Peabody J, Sarle R, et al. Technique of da Vincirobot-assisted anatomic radical prostatectomy. Urology, 2002, 60(4):569-572.
  • 3Patel VR, Coelho RF, Palmer KJ, et al. Periurethral SuspensionStitch During Robot-Assisted Laparoscopic RadicalProstatectomy: Description of the Technique and ContinenceOutcomes. Eur Urol, 2009, 56(3):472-478.
  • 4Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA CancerJ Clin, 2010, 60(5): 277-300.
  • 5李鸣,张思维,马建辉,陈万青,那彦群.中国部分市县前列腺癌发病趋势比较研究[J].中华泌尿外科杂志,2009,30(6):368-370. 被引量:171
  • 6HuJC, Wang Q, Pashos CL, et al. Utilizaton and outcomes ofminimally invasive radical prostatectomy. J Clin Oncol, 2008, 26(14):2278-2284.
  • 7Patel VR, Coelho RF, Chauhan S, et al. Continence, potency andoncological outcomes after robotic-assisted radical prostatectomy:early trifecta results of high volume surgeon. BJU Int, 2010,106(5):696-702.
  • 8Ficarra V,Novara G, Fracalanza S,et al. A prospective,non-randomized trial comparing robot-assisted laparoscopic andretropubic radical prostatectomy in one European institution. BJUInt, 2009, 104(4): 534-539.
  • 9Palmer KJ, Coelho RF, Patel VR. Tips and tricks for roboticprostatectomy: a sept-by-step approach. In: Patel VR. Roboticurologic surgery. 2nd ed. Springer, 2012,139-148.
  • 10Menon M, Shrivastava A, Kaul S, et al. Vattikuti Instituteprostatectomy: contemporary technique and analysis of results.Eur Urol, 2007,51(3): 648-658.

二级参考文献14

  • 1张思维,陈万青,孔灵芝,李连弟,鲁凤珠,李光琳,孟佳,赵平.中国部分市县1998~2002年恶性肿瘤的发病与死亡[J].中国肿瘤,2006,15(7):430-448. 被引量:171
  • 2李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第1卷(1988-1992).北京:中国医药科技出版社,2002:263-289.
  • 3李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第2卷(1993-1997).北京:中国医药科技出版社,2003:269-295.
  • 4李连弟,饶克勤,孔灵芝,等.中国试点市县恶性肿瘤的发病与死亡第3卷(1999-2002).北京:人民卫生出版社,2007:314-316.
  • 5Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents. Vol. VIII. IARC Scientific Publication No. 155. Lyon: IARC, 2002: 745-747.
  • 6Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents. Vol. IX. IARC Scientific Publication No. 160. Lyon: IARC, 2008.
  • 7Jensen OM, Parkin DM, MacLennan R, et al. Cancer registration: principles and methods. IARC Scientific Publication No. 95. Lyon.. IARC, 1991.. 101-107.
  • 8Parkin DM, Chen VW, Ferlay J, et al. Comparability and quality control in cancer registration. IARC Technical Report No. 19. Lyon.. IARC, 1994: 35-49.
  • 9Felay J, Burkhard C, Whelan S, et al. Check and conversion programs for cancer registries. IARC Technical Report No. 42. Lyon: IARC, 2005: 11-38.
  • 10Felay J. The IARCcrgTools program, http://www, iacr. com. fr/iarccrgtools, htm. IACR. Lyon. 2006.

共引文献170

同被引文献112

  • 1吴训,于德新,谢栋栋,王毅.腹腔镜前列腺癌根治术与开放术式的疗效比较Meta分析[J].中华临床医师杂志(电子版),2012,6(16):4773-4779. 被引量:19
  • 2王国民,陈伟.泌尿系统肿瘤治疗的进展与展望[J].肿瘤防治研究,2014,41(2):97-101. 被引量:25
  • 3王国民,徐志兵,朱延军,徐叶青,陈绍亮,曾昭冲,程文英.^(125)I放射性粒子永久植入治疗前列腺癌[J].中华泌尿外科杂志,2005,26(4):263-266. 被引量:18
  • 4马志方,王东文.机器人手术在泌尿外科的应用和研究进展[J].中华泌尿外科杂志,2005,26(5):355-356. 被引量:4
  • 5富莉芳,张建华.对前列腺癌根治术患者控尿功能评估及康复训练[J].护理管理杂志,2007,7(7):29-30. 被引量:10
  • 6Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013 [ J]. CACancer J Clin, 2013,63( 1) : 11-30.
  • 7Kupelian PA, Potters L, Khuntia D,et al. Radical prostatectomy,external beam radiotherapy <72 Gy, external beam radiotherapy >or = 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer[ J]. Int JRadiat Oncol Biol Phys, 2004,58(1) : 25-33.
  • 8Li twin MS, Gore JL, Kwan L, et al. Quality of life after surgery,external beam irradiation, or brachytherapy for early- stage prostatecancer[ J]. Cancer, 2007,109( 11) : 2239-2247.
  • 9Frank SJ, Pisters LL, Davis J, et al. An assessment of quality of lifefollowing radical prostatectomy,high dose external beam radiationtherapy and brachytherapy iodine implantation as monotherapies forlocalized prostate cancer[ J]. J Urol, 2007 , 177(6) : 2151-2156.
  • 10Borchers H, Kirschner-Hermanns R, Brehmer B, et al. Permanent1251-seed brachytherapy or radical prostatectomy : a prospectivecomparison considering oncological and quality of life results [ J ].BJU Int, 2004, 94(6): 805-811.

引证文献13

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部